Merck Pulls The Plug On Covid-19 Vaccine Program After Disappointing Trial Data

The pharma heavyweight will now focus on developing two experimental Covid-19 drugs.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Manufacturing /manufacturing Innovation /innovation Science /science Healthcare /healthcare Editors' Pick editors-pick Breaking breaking-news Coronavirus Source Type: news